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and conventional t l~  (CT) on 131 pa~ants wtllt pulmonary hypedassion 
(PH) [82 females, 49 males; mean age 38 :E 13 years]. Ninely eight patients 
had IXimon/pulrnsnary ~ n  while 33 had thrombo-emb~ic disease. 
Severity of the disease was determined by functional ,class, haemodycand~s 
and mixed venous oxygen saturaZion (SvO~). Patients were categorized into 
group t (SvO~ >_ SO%) and group 2 (SvO= < SO%), and were eitt~ uasted 
with PGI2 or CT. End point was either death, heart-lung Iransplastaflon or 
thrombo.endanerectomy, 
Group 1 (n = s~) Gm.p 2 (n = ~),  , 
PAPm (ram Hg) 60.0 4.16.3 67.~ 4.15,4" 
RAPm (ram Hg) 8.54-6.0 13.44-5.8" 
SvO2 (%) . 6G.54-6.1 50.74-7.2" 
(31 (Ulllin/nt <) 2,01 4- 0.66 1,73 4. 0.46* 
Me~l ~- SD, -p < 0.05 
In group 2, palionts b'e,Med with PGI~ had a greater median sun/ival (239 
days with CT vs, 685 days with PGI~, p < 0,05). There was no significant 
ddferaoca between CT and PGI2 in group 1 (median sun,hr,: 94t days with 
CT vs. 986 days with PGI2). There was no significant (Efference in sundval 
between acute mspondem and aon-mspondere treatod with PGI2; 20% drop 
in pulmonary vascular resistance considered as target dudng dght heart 
calhetedsation ( l, edian suntival: 986 days in acute req)onde~ vs. 786 days 
in norH'esponders; p = 0.228). Continuous in~s~n of PGFa has a role in the 
trcatment of PH where SvO,a is < 60%. Acute vasodilator esponse does nst 
have an effect on the long term outcome of severe PH when treated with 
PGI~. 
VALVULAR DISEASE 
Echocardiographic Score Predicts In-Hospital 
in Patients Undergoing Perculaneous 
Bal loon Mitral Valvuloplasly 
Ma~ J. Eisenberg, Raj Ball~l, Paul ~ Heldonmich, ir.mr~oedy J. Brown, 
Bdan P. Griffin, Murat Tuzcu. Cleveland Clini~ FoundaUon, Cleveland, OH 
Background: Echocardiographic score is known to be pre~ctive of clinical 
ot~:ome in patients undergoing pefcutaneous ballOon mltral va lvu l~ 
(PBMV), but it is unlmown whether this score can also be used to Ixedict 
in4tespitol cost. Met/xxfs: Prepmcedum ~ scores, baseline 
dinlcal chamcted~cs, and total in - t~ costs were examined among 45 
patJests who underwant PBMV between Januaw 1,1992 and Janusxy 1,1995. 
R~ults: Patients ranged in age from 18 to 71 years and had prelxocedum 
echesardingraphic; s ores ranging from 4 to 12. Following PBMV, mean mitra] 
v'al~ area inoreased from 1.1 :E 0.3 fu 2.4:E 0.6 cm 2 (p = 0,0001), and mean 
pressure gradient deareased Irom 18.3 :*: 5.9 to 6.7 ~ 2.7 mm Hg (p = 0.0001). 
In-I Ios~ cost for the 45 paltenls ranged flora $3,591 to $70,975 (mean: 
$9,417; median: $5,311). Univariate and multiple linear regression analyses 
demonstrated ~ among the variables examined, echo~rap ldc  scorn 
(p = 0.0007), age (p = 0.01 ), and pre-procedum itral valve gradiaot (p = 0.03) 
were associated with tn-hospitalcesL Regn~sion modeling suggested thatfur 
evely increase in pre-procedure chocald~ngraphic Score of one grade, there 
was an increase in indlaspi~ cost of $2,663. Condus/on: ECtlOcal~ographic 
score appears to be pred~clJve of in-h0spil~l cast in paf~entS Undergoing PBMV. 
Consequently, patients who have elevated e~¢ardiographi~ scores should 
be slrongly considered for alternative therapy, 
~ Compadson of LOw.Dose and Standard-Dose 
Oral Anticoagulant Therapy in Patients With a 
Mechanical Prosthesis. 1 i~  AREVA Multicenter 
Tdal 
BemanJ lung, Jean Acar, Jean Paul Tefype, Jean Piene Bolsasl, on behalf 
of the invesligafus of the AREVAgroup, Card /~ Depat'anent; H0p#a/ 
Tenon, Paris; SenK~a de Phan~e Clinique, Lyon ~Franoe 
The main puq0ose of the AREVA prospective b'ial was to compare moderate 
oral anticoagulation (INR 2-3) wi~ the usual regimen (INR 3--4.5) after a 
single-valve replacement 0/R) with a mechanical prosthesis, In the infllal 
design of the study, patients (pts) were randomly allocated to receive eilher 
Omnicarbone (OM) or a Saint-Jude (SJ) prosthesis. This allocation was 
suppressed after t year due to problems of availability of OM and all stto- 
Se~!.u~ I~  n~oive¢! .S.J. A~.er VR, pts were ran(~mJzed in the INR target 
r'4nges of 2-3 or 3-4.5. Pts were included if they were ~ged between 18 and 
75 ym, In sinus nJthm, aod if left aMnl diameter wao < 50 m in TM esho, The 
endpoints were thmmbeembolic events as assessed Irom clinical data and 
on CT brain scans, and hemorrhagic events. All blood ~es  cogected for 
INR detenninalJon dudng follow-up (FU) were analyzed, 
From 1991 to 1994, 434 pts underwent VR (aortic 4t5 pts, rnitral 19 pts) 
wilh 354 SJ and 80 OM; 380 were randomized fur INR: 188 for |NR 2-3 
and 192 fur INR 3-4.5. Mean FU was 2.2 [1-4] yrs. From the analysis of 
18002 INR, the mean of the ~ median of INR was 2.80 :E 0.41 inthe 
group 2-3 and 3.23 :~ 0.39 in the group 3-4.5 Co < 0,0001). Results were 
as follows: 
INR 2-3 INR 3-4.5 p 
Pts. wah >_ 1 mrombo.embor¢ event lO 9 0.78 
Pts. wil~ > I major I~event  13 19 0~9 
Pts. with > 1 ~ event 34 ~ O.Ol 
In aondusion, moder'ale ant~ad Jon  allows a de~e~se in gm iaoldence 
of hemonhag~ ~ents, without a~ecling the incidence of thrombeento~ 
evente, in selected pts w~h a mechank~ ixaslbesis, mainly Sj proslbes~ in 
ao~c pesitton. 
~ I)ynamic Orifice Area VariallJons in Functional 
Arnold A. Fonlaino, ~mqiu He, Jeffrey T. Ellis, Ehud Schwammenthal, 
Robert A. Levine, AjitR Yogaoalhan. Georg/a/nst. of Tec~,  Atfat~a, 
GA; M.~---~huse~ Generat -k~., Boston, MA 
Recent stod~ in I~ents w~h hacbenel ~ rngurg~a~ (MR) have 
shown a paradoxical desmase in eWective ~ odfice area (EROA) in 
midsystole desp~ peak driving pmssm~. This behavior soggesto a ~nge 
in the forca balance aclJng on the mi'cal eaflets, with i ~  LV pressure 
counterast~g the lealMchordal tenston that n~ts  ~ hi the d~ated 
LV. Ttds concept was explomd in an in vitro seffing to pemdt independent 
~ofbeth¢~r~glxessumand lea~.d~geometryandtens~ 
(d4icutt in ~o), Seven excised porcine rn~al valves were tested m~cler 
physiologic Puisat~ flow in an LV model; tor e~h, we independency varied 
PM Pesilkm (IX)St., laL and apical oTm~) ,  annular size, aed ddving 
pressure (90-150 mmHg). Instanteneous EROA was calculated ¢Smctly from 
continuity (o~rectly mcasuted MR flow rate/CW ~ or~,ce velocity) and 
;v~.-ec~y from ~ flow and pressure wavefurms (moSSed Bernoulli 
equa~on). The dmaz~ of leaget coalXation wiemut ~ gap was ~ 
by 2D echo. Rest/S: 1 ) ClirdcaUy obaorved eady and late s ~  peaks in 
MR flow and EROA were reproduced by ts0~let te th~ b~ this model, 
with the decrease in EROA c o n ~  to ds~ng LV ddving pressure, 2) 
Greater k~mm ~ mod,e~ Zncmased the eady sys~ ~ 
closing volume before completo couplal~n (delayed v',dve cJusum). 3) MR 
increased as dura~an of lealtel o o ~  deoreased (r = 0,61), 
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Conc/~s/ons: Dynsmic v~alJon of EROA can be mprnduced invilroby 
inc~_ __ ~,d leallet elhedng and phasic LV pressure, consistant wilh a mecha- 
nism in whid~ an a / t~ foce ba/arce a~/ng on the /ea~ ( ~  ~s  
co~ng) is central to cmating ~ MR EROA. 
VASCULAR/CORONARY DISEASFJTHROMBOSIS- 
BASIC 
Rapid Aottvatkm of MitogewAcU~rated Protein 
Kinase (MAPK) by Balloon Angioplasty of in Vivo 
Pordne Coronary and Carotid Arteries 
J. Mario Pyles, Michaet T. Frankrm, Khtwrar Metal, Robert L Wilansky, 
Leonard R Adam, ~ L Mamh. Krarme~ institute of ~ and RL 
Roude~ssh VN~C, ~ IN: Boston ek~ed~aS Research Zm#tuto, 
Boston, MA 
Vasc~ar restano~ involves contmc~le, proliferate, and remodeling re- 
sponses of the aderis] wall to ovecstmtch injury. MAPK is hnldicateci in 
contraclge and ixolifera~e responses of vascular smooth muscle. Studies 
of ixm ine carotid ~ s t~ have shown t~at mechanical stretch leads 
to the acSva~m of MAPK in vitro. We themfuns analyzed the acute effect 
of mecRBnical ove~lmtch on MAPK activity in porcine coronary and carotid 
artedas in vivo. 
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